PARP inhibitor response in prostate cancer
- PMID: 36765184
- DOI: 10.1038/s41585-023-00735-0
PARP inhibitor response in prostate cancer
Comment on
-
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.Nat Commun. 2023 Jan 17;14(1):252. doi: 10.1038/s41467-023-35880-y. Nat Commun. 2023. PMID: 36650183 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
